Combating antibiotic resistance with CBD
A recent study conducted by researchers in Queensland, Australia, highlighted the potential of CBD to fight certain bacterial sources that are usually resistant to antibiotics.
Antibiotic resistance is a real concern for the medical community. According to the World Health Organization (WHO), it could even be one of the greatest threats to global health and food security.
A global study (1) - coordinated by a British economist - reported that approximately 700,000 people would die each year due to antimicrobial resistance (antibiotics, antivirals, antifungals and antiparasitic drugs). If the trends continue in the coming years, the number of deaths could reach 10 million in 2050, more than those related to cancer (8.2 million).
CBD as an alternative to antibiotics?
Researchers from the University of Queensland have decided to study the effectiveness of CBD against infections (2) such as boils or anthrax, two skin diseases caused by bacteria. To carry out their experiments, the researchers performed tests on mice. And the results were very conclusive: CBD showed anti-microbial action against Gram-positive bacteria, which are often responsible for skin infections. In addition, cannabidiol would also have overcome various bacterial strains known to be resistant to conventional antibiotics, such as Staphylococcus epidermidis, which is resistant to methicillin.
Mark Blaskovich, the lead author of the study and professor at the University of Queensland, is enthusiastic about this discovery: "Given the known anti-inflammatory effects of cannabidiol, its harmlessness in humans and its potential for oral administration, this is a promising new antibiotic," he says.